The Aβ(1–38) peptide is a negative regulator of the Aβ(1–42) peptide implicated in Alzheimer disease progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Aβ(1–38) peptide is a negative regulator of the Aβ(1–42) peptide implicated in Alzheimer disease progression
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-11
DOI
10.1038/s41598-020-80164-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
- (2020) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- Age- and sex-dependent profiles of APP fragments and key secretases align with changes in despair-like behavior and cognition in young APPSwe/Ind mice
- (2019) Maa O. Quartey et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease
- (2019) Lei Yu et al. JAMA Neurology
- Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer’s disease progression
- (2019) Filip Liebsch et al. Nature Communications
- Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms
- (2019) Suman De et al. Nature Communications
- Region- and activity-dependent regulation of extracellular glutamate
- (2018) Nawrin F. Pinky et al. JOURNAL OF NEUROSCIENCE
- Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease
- (2018) Jennifer N.K. Nyarko et al. NEUROSCIENCE
- BeStSel: a web server for accurate protein secondary structure prediction and fold recognition from the circular dichroism spectra
- (2018) András Micsonai et al. NUCLEIC ACIDS RESEARCH
- Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study
- (2018) Saima Hilal et al. Alzheimers Research & Therapy
- Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
- (2018) Jochim Reinert et al. JOURNAL OF ALZHEIMERS DISEASE
- Aβ42/Aβ40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer’s Disease
- (2018) Ning Tang et al. JOURNAL OF ALZHEIMERS DISEASE
- Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease
- (2018) Shaomin Li et al. Acta Neuropathologica Communications
- Why do trials for Alzheimer’s disease drugs keep failing? A discontinued drug perspective for 2010-2015
- (2017) Dev Mehta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
- (2017) Nobuto Kakuda et al. Acta Neuropathologica Communications
- Ion Channel Formation by Amyloid-β42Oligomers but Not Amyloid-β40in Cellular Membranes
- (2016) David C. Bode et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
- (2016) Sonia Mazzitelli et al. Acta Neuropathologica Communications
- Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering
- (2016) Bo Zhang-Haagen et al. PLoS One
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration
- (2015) Peng Liu et al. Cell Reports
- Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid
- (2014) Sarah K. Fritschi et al. BRAIN
- Distinct circular dichroism spectroscopic signatures of polyproline II and unordered secondary structures: Applications in secondary structure analyses
- (2014) Jose L. S. Lopes et al. PROTEIN SCIENCE
- COX19 mediates the transduction of a mitochondrial redox signal from SCO1 that regulates ATP7A-mediated cellular copper efflux
- (2013) Scot C. Leary et al. MOLECULAR BIOLOGY OF THE CELL
- Molecular Plasticity Regulates Oligomerization and Cytotoxicity of the Multipeptide-length Amyloid-β Peptide Pool
- (2012) Annelies Vandersteen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways
- (2012) Jasmin Bartl et al. JOURNAL OF NEURAL TRANSMISSION
- Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease
- (2012) Gawain McColl et al. Molecular Neurodegeneration
- The Generation of Definitive Neural Stem Cells from PiggyBac Transposon-Induced Pluripotent Stem Cells Can Be Enhanced by Induction of the NOTCH Signaling Pathway
- (2012) Ryan P. Salewski et al. STEM CELLS AND DEVELOPMENT
- Size-dependent neurotoxicity of β-amyloid oligomers
- (2010) Paulius Cizas et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Synaptotoxicity of Alzheimer Beta Amyloid Can Be Explained by Its Membrane Perforating Property
- (2010) Fernando J. Sepulveda et al. PLoS One
- β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution
- (2009) Zhenglin Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease
- (2009) Volker Welge et al. JOURNAL OF NEURAL TRANSMISSION
- Independent Generation of Aβ42 and Aβ38 Peptide Species by γ-Secretase
- (2008) Eva Czirr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Episodic swimming behavior in the nematode C. elegans
- (2008) R. Ghosh et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Prediction of Alzheimer’s Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides
- (2008) K. Höglund et al. Neurodegenerative Diseases
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now